Our latest: analysis of RWD from >4 million source plasma collections following a personalized nomogram supports findings from IMPACT RCT. Presented at AABB in Nashville🎸this weekend; now published in #TRANSFUSION: onlinelibrary.wiley.com/doi/full/10.11… #PrecisionTransfusionMedicine #AABB23

Real world evidence published in TRANSFUSION suggests a novel technology-enabled personalized nonogram may increase the yield of plasma from source plasma collections. Read more at: bit.ly/RWE1123 #Blooducation #TransfusionMedicine #BloodDonation AABB @HaeomoneticsCorp

The BEST Collaborative study finds high use and variability in blood donor incentives globally. Read more at: bit.ly/BEST_1223 #Blooducation #TransfusionMedicine AABB

🤩Welcome 2024! #Blooducation. This is going to be the year of the platelet: Cold stored, whole blood, low yield, freeze dried. We are going to learn that they do more than just stick. Cell therapy advancements. From treatment to cure, the answer is within us. Optimizing

A new study in @BloodJournal uses deep learning to develop models to forecast platelet transfusion risk, which performed best for hematology-oncology patients. Read more at: bit.ly/Deep0124 #Blooducation #TransfusionMedicine AABB

☕Next Transfusion News #BlooducationBaristas on Laboratory Advocacy 📅 Friday, January 26 at 11 AM ET Join us for a conversation with master laboratory educators who will be discussing developing the next generation of lab leaders Livestream here @blooducationbar

A new murine model suggests complement activation drives antibody-mediated transfusion-related acute lung injury by macrophage trafficking and formation of neutrophile extracellular traps (NETS). Read more: bit.ly/TRALI_24, #Blooducation #TransfusionMedicine #BloodJournal

#BlooducationBaristas - Laboratory Advocacy x.com/i/broadcasts/1…

Join us live now! x.com/BlooducationBar

A consensus statement in The Lancet Global Health identifies strategies to address global blood deserts (e.g., civilian walking blood banks, intraoperative autotransfusion, & drone-based blood delivery). Read more: bit.ly/desert0224 #Blooducation #TransfusionMedicine #GlobalHealth AABB

⚠️⚠️⚠️⚠️ Today's Global Transfusion Webcast is moving to Zoom due to technical difficulties. Join us at 10 a.m. EDT for a discussion on the three pillars of a sustainable blood supply. Link to join: us02web.zoom.us/j/83305132805?… Meeting ID: 833 0513 2805 Passcode: 238068

New study in Blood Advances characterizes transfusion needs and patterns after CAR T-cell therapy for B-cell lymphoma. Read more at: bit.ly/cart0424 #Blooducation #TransfusionMedicine AABB

Tranexamic acid treatment does not reduce hematoma growth in patients with intracerebral hemorrhage, according to STOP-MSU phase 2 trial in The Lancet Neurology. Read more at: bit.ly/tranx0524 #Blooducation #TransfusionMedicine AABB

Creutzfeldt-Jakob disease (CJD) is a rare, fatal prion disease. From 1995-2023, no cases of transfusion-transmitted classic CJD were detected in a U.S. study, suggesting a very low risk. Read more at: bit.ly/cjd0724 #Blooducation #TransfusionMedicine AABB

New study finds genetic factors influencing RBC storage lesions & hemolysis. Key findings: L-carnitine levels rise w/ age, higher in males & Asians. Genetic polymorphisms impact carnitine in stored RBCs. Read more: bit.ly/carnitine0724 #Blooducation #TransfusionMedicine AABB

After a way-too-long hiatus, the #BBGuyPodcast 🎙️🎧 is back, baby! Check out "Essentials of Transfusion Support in HPC Transplant " with Brian Adkins TODAY at BBGuy.org/104 and all podcast outlets. I've missed you, learners! #blooducation

New study in Blood Advances suggests donor-specific antibody thresholds predict platelet transfusion response for HLA-alloimmunized patients. Read more at: bit.ly/dsa0924 #Blooducation #TransfusionMedicine

New meta-analysis on platelet irradiation: Among 44 studies, no clinically meaningful differences found between irradiated & non-irradiated platelets in quality or transfusion outcomes. Read more at: bit.ly/rbc1224 #Blooducation #TransfusionMedicine AABB

Is it time to reconsider leukoreduction for whole blood in life-threatening hemorrhage? A new review from the THOR_Network-AABB Joint Working Group examines the benefits and limitations of LR for low-titer group O whole blood. bit.ly/4gBqBPf

SAHARA trial: For pts w/ aneurysmal subarachnoid hemorrhage & anemia, liberal RBC transfusion (Hb<10 g/dL) showed no benefit over restrictive transfusion (Hb<8 g/dL) in neurological outcomes, mortality, or QoL. Read more: bit.ly/2rbc24 #Blooducation #TransfusionMedicine